Cutia Therapeutics
Research Cutia Therapeutics (2487.HK) on Bullrun: market cap HKD 320.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2487.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 320.89M
- Financial periodFY2025
- RevenueCNY 336.15M
- Revenue growth20.2%
- Net income-CNY 340.19M
- Free cash flow-CNY 302.97M
- Gross margin58.2%
Valuation Snapshot
latest market cap is HKD 320.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 336.15M | -CNY 340.19M | -CNY 302.97M | 58.2% | -1.03 | CNY 265.01M | CNY 317.39M | CNY 885.28M |
| FY2024 | CNY 279.62M | -CNY 433.81M | -CNY 468.66M | 51.3% | -1.41 | CNY 385.67M | CNY 320.94M | CNY 974.73M |
| FY2023 | CNY 137.62M | -CNY 1.96B | -CNY 437.23M | 51.6% | -9.6 | CNY 473.12M | CNY 243.76M | CNY 1.35B |
| FY2022 | CNY 11.37M | -CNY 555.84M | -CNY 371.50M | 69.8% | -1.83 | CNY 465.87M | CNY 54.13M | -CNY 1.25B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 320.89M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Cutia Therapeutics
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People's Republic of China and Hong Kong. It focuses on the dermatology treatment and care therapeutic areas, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management medication.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cutia Therapeutics's market cap?
Cutia Therapeutics's market capitalization is HKD 320.89M.
What does Cutia Therapeutics do?
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People's Republic of China and Hong Kong. It focuses on the dermatology treatment and care therapeutic areas, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management medication.